That's a good example. Generics is what I was going to come back to next. For instance in our Government of Canada plan, I'm on a prescription and my doctor wrote the brand name. I pay more for that at the counter whereas if I have the generic, I don't pay more. It's really a consumer choice then at the end between the two. As long as the physician has confirmed with me that they are equitable, then this is my own decision around that cost point.
Are you satisfied generally that the introduction of generics is happening efficiently in Canada? As the patent protection falls off and you see them coming on, are adequate generic processes in place and are those drugs being substituted in efficiently for Health Canada?